Home > Press > Nanostart AG: First-half figures 2015 published and new supervisory board elected : Publication of first-half figures 2015 - Shareholders' meeting elected new supervisory board
Abstract:
Frankfurt-based nanotechnology investment company, Nanostart AG, today publishes the financial results for the first half-year 2015. The semi-annual report is available as of now for download from the website of the corporation at www.nanostart.de.
Moreover, Nanostart AG announces a change in the supervisory board. Mr. Stefan Schütze and Bernd Förtsch, already appointed by the court, have been elected to the supervisory board at the annual shareholders' meeting of the corporation. Professor Dr. Wolfgang M. Heckl, who had been executing the office since 2005 and whose term in office ended upon conclusion of the shareholders' meeting on 20 August 2015, was not available for re-election.
Mr. Förtsch, commenting, "I would like to thank Professor Heckl in the name of the supervisory board for his many years of dedicated and constructive work."
Stefan Schütze, accredited as a lawyer (LL.M. in mergers and acquisitions), has long-term experiences as an Attorney-at-Law, legal advisor and as member and chairman of several supervisory boards of listed investment companies.
####
About Nanostart AG
Nanostart is an investment company with the focus on nanotechnology. Nanostart invests in young and promising nanotechnology-based companies. Nanostart invests globally and at different phases of development. When talking about investments, the company focusses on business lines like cleantech, life sciences or IT/electronics. Nanostart AG has its headquarters in Frankfurt am Main, Germany.
Disclaimer
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia, or Japan.
For more information, please click here
Contacts:
Nanostart AG
phone.: +49 69 219396 0
fax.: +49 69 219396 150
Copyright © Nanostart AG
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||